Adynxx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 6.06M and sold 416.69K ADYX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 6.06M shares
Sell 416.69K shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 22, 2019
Buy
Common Stock
J-Other
Flesher Gregory J.
Director 0
Value: $0
Jul 22, 2019
Buy
Common Stock
J-Other
Flesher Gregory J.
Director 0
Value: $0
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 1 577
Value: $2K
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 1 577
Value: $2K
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 26 358
Value: $80.7K
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 26 358
Value: $80.7K
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 1 577
Value: $2K
May 29, 2019
Buy
Stock Option (Right to Buy)
Gonzalez Dina
Controller
Officer 1 577
Value: $2K
May 03, 2019
Buy
Common Stock
Tpg Group Holdings (sbs) Advisors, Inc.
Insider
Other 0
Value: $0
May 03, 2019
Buy
Common Stock
Dp Viii Associates, L.p.
10 Percent Owner
10% Owner 0
Value: $0
May 03, 2019
Buy
Common Stock
Domain Partners Viii, L.p.
10 Percent Owner
10% Owner 0
Value: $0
May 03, 2019
Buy
Common Stock
Domain Partners Viii, L.p.
10 Percent Owner
10% Owner 0
Value: $0
May 03, 2019
Buy
Common Stock
Dp Viii Associates, L.p.
10 Percent Owner
10% Owner 0
Value: $0
May 03, 2019
Buy
Common Stock
Tpg Group Holdings (sbs) Advisors, Inc.
Insider
Other 0
Value: $0
May 03, 2019
Buy
Common Stock
A-Award
Abel Stan E
Director
Director 54 117
Value: $0
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Abel Stan E
Director
Director 27 940
Value: $85.5K
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Abel Stan E
Director
Director 198
Value: $275
May 03, 2019
Buy
Common Stock
A-Award
Weber Eckard
Director
Director 85 254
Value: $0
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Weber Eckard
Director
Director 55 879
Value: $171.0K
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Weber Eckard
Director
Director 396
Value: $550
May 03, 2019
Buy
Common Stock
A-Award
Podlesak Dennis
Director
Director 85 254
Value: $0
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Podlesak Dennis
Director
Director 55 879
Value: $171.0K
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Podlesak Dennis
Director
Director 396
Value: $550
May 03, 2019
Buy
Common Stock
A-Award
Mamet Julien
Chief Scientific Officer
Officer 240 454
Value: $0
May 03, 2019
Buy
Stock Option (Right to Buy)
A-Award
Mamet Julien
Chief Scientific Officer
Officer 158 149
Value: $483.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ADYNXX INC.
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of fo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE